Stock listing

PEPG Stock Price, News, Filings & Events — Pepgen Inc.

Selected listing: PEPG · NASDAQ · USD · US

This page tracks Pepgen Inc.'s PEPG:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PEPG:NASDAQ. PEPG:NASDAQ is the stock-level entry point for investors researching Pepgen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pepgen Inc. (Ticker: PEPG) is a publicly traded company based in the United States, with a market capitalization of approximately $133.5 million. The company is focused on developing innovative therapies for genetic diseases. Pepgen aims to address unmet medical needs through its advanced research and development efforts.

PEPG:NASDAQUSDUSUpdated September 11, 2026
Pepgen Inc. logo
Ticker
PEPG:NASDAQ
Asset type
Stock
Market cap
$206.4M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Pepgen Inc. PEPG:NASDAQ stock context

This page tracks Pepgen Inc.'s PEPG:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PEPG:NASDAQ. PEPG:NASDAQ is the stock-level entry point for investors researching Pepgen Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pepgen Inc. (Ticker: PEPG) is a publicly traded company based in the United States, with a market capitalization of approximately $133.5 million. The company is focused on developing innovative therapies for genetic diseases. Pepgen aims to address unmet medical needs through its advanced research and development efforts.

Latest news from Pepgen Inc.

All Pepgen Inc. news →

Pepgen Inc. earnings calls

Research Pepgen Inc.

Alternate listings